Title
Category
Credits
Event date
Cost
Literature Review: Efficacy and Safety of Sparsentan versus Irbesartan in Patients with IgA Nephropathy (PROTECT): 2-Year Results from a Randomised, Active-Controlled, Phase 3 Trial
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
11/19/2024
Board Case Conference: Neonatal Hyperkalemia
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
11/19/2024
Pulmonary Atresia with Ventricular Septal Defect: Pathophysiology and Right Ventricular Suicide Prevention
  • 1.00 ABS MOC II
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
11/19/2024
Re-Evaluating Infection Prevention Recommendations For Patients with Chemotherapy – Induced Neutropenia
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
11/19/2024
Wellness: A Foundation for Joy in Life
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
  • 1.00 Ethics
11/20/2024
Gynecologic Cancer Case Presentations
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
11/20/2024
Superficial Radiation Therapy for Non-Melanoma Skin Cancers: The Surgeon's Perspective
  • 1.00 ABS MOC II
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
11/20/2024
Shortening the Curve for Surgical Skill Acquisition
  • 1.00 ABS MOC II
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
11/20/2024
Eliminating Toxicity in the Workplace
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
  • 1.00 Ethics
11/20/2024
Differential Diagnosis and Management of Suprasellar Tumors and of Supratentorial Tumors
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
11/20/2024

Pages